Brian Conway

6.1k citations

86 papers · 2.1k indexed · h-index 25

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
Virology top 1%
- HIV Research and Treatment

Papers in ⓘ

Hepatology 55
- Hepatitis C virus research 55
Virology 26
- HIV Research and Treatment 26

Co-authors: Jason Grebely (24 shared papers)Jesse D. Raffa (12 shared papers)Mark Tyndall (5 shared papers)Fiona Duncan (10 shared papers)Krista Genoway (6 shared papers)Mel Krajden (5 shared papers)Stanley DeVlaming (9 shared papers)Calvin Lai (2 shared papers)
Journals: JAIDS Journal of Acquired Immune Deficiency Syndromes (7 papers)Journal of Hepatology (7 papers)Clinical Infectious Diseases (6 papers)HIV Clinical Trials (4 papers)International Journal of Drug Policy (4 papers)
Partner nations: Canada United States Australia

In The Last Decade

Brian Conway

83 papers receiving 2.0k citations

Peers

Countries citing papers authored by Brian Conway

Since Specialization

Citations

This map shows the geographic impact of Brian Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Conway more than expected).

Fields of papers citing papers by Brian Conway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Conway. The network helps show where Brian Conway may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian Conway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian Conway Line = papers co-authored together Brian Conway links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Barriers associated with the treatment of hepatitis C virus infection among illicit drug users Drug and Alcohol Dependence ·Jason Grebely, Krista Genoway, Jesse D. Raffa, Gurbir Dhadwal, Tasleem Rajan, Grey Showler, Kate Kalousek, Fiona Duncan, Mark Tyndall, Chris Fraser, Brian Conway, Benedikt Fischer	2007	165
2	Sex, Race, and Geographic Region Influence Clinical Outcomes Following Primary HIV-1 Infection The Journal of Infectious Diseases ·Amie L. Meditz, Samantha MaWhinney, Amanda A. Allshouse, William J. Feser, Martin Markowitz, Susan J. Little, Richard D. Hecht, Eric S. Daar, Ann C. Collier, Joseph B. Margolick, J Michael Kilby, Jean‐Pierre Routy, Brian Conway, John Kaldor, Jay A. Levy, Robert T. Schooley, David A. Cooper, Marcus Altfeld, Douglas D. Richman, Elizabeth Connick	2011	138
3	A Multicenter Observational Study of the Potential Benefits of Initiating Combination Antiretroviral Therapy during Acute HIV Infection The Journal of Infectious Diseases ·Frederick Hecht, Lei Wang, Ann C. Collier, Susan J. Little, Martin Markowitz, Joseph B. Margolick, J Michael Kilby, Eric S. Daar, Brian Conway, Sarah Holte, (unknown)	2006	131
4	Hepatitis C virus reinfection in injection drug users Hepatology ·Jason Grebely, Brian Conway, Jesse D. Raffa, Calvin Lai, Mel Krajden, Mark Tyndall	2006	115
5	A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B Hepatology ·Patrick Marcellin, Herve Momméja-Marin, Stephen L. Sacks, George Lau, D. Séréni, Jean–Pierre Bronowicki, Brian Conway, Christian Trépo, Robert M. Blum, Byung Chul Yoo, Elsa Mondou, J. Sorbel, A. Lynn Snow, Franck Rousseau, Hyo‐Suk Lee	2004	106
6	Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support European Journal of Gastroenterology & Hepatology ·Jason Grebely, Elizabeth Knight, Krista Genoway, Mark Viljoen, Milan Khara, Doug Elliott, Lesley Gallagher, Michelle Storms, Jesse D. Raffa, Stanley DeVlaming, Fiona Duncan, Brian Conway	2010	103
7	Factors Associated with Spontaneous Clearance of Hepatitis C Virus among Illicit Drug Users SHILAP Revista de lepidopterología ·Jason Grebely, Jesse D. Raffa, Calvin Lai, Mel Krajden, Brian Conway, Mark Tyndall	2007	88
8	Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection International Journal of Drug Policy ·Jason Grebely, Krista Genoway, Milan Khara, Fiona Duncan, Mark Viljoen, Doug Elliott, Jesse D. Raffa, Stanley DeVlaming, Brian Conway	2007	87
9	Directly Observed Therapy for the Management of HIV-Infected Patients in a Methadone Program Clinical Infectious Diseases ·Brian Conway, Jennie Prasad, Robert J. Reynolds, John Farley, Michelle Jones, Salima Jutha, Nadine Smith, Annabel Mead, Stanley DeVlaming	2004	79
10	Cohort Profile: The Canadian HIV-Hepatitis C Co-infection Cohort Study International Journal of Epidemiology ·Marina B. Klein, Sahar Saeed, Hong Yang, Jeffrey Е. Cohen, Brian Conway, C. Cooper, Pierre Côté, Joseph Cox, M. John Gill, David Haase, S. Haider, Joan Montaner, Neora Pick, Anita Rachlis, Danielle Rouleau, Roger Sandre, Mark Tyndall, Sharon Walmsley	2009	73
11	Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users Journal of Gastroenterology and Hepatology ·Jason Grebely, Jesse D. Raffa, Caite Meagher, Fiona Duncan, Krista Genoway, Milan Khara, Mark McLean, Annabel Mead, Mark Viljoen, Stanley DeVlaming, Chris Fraser, Brian Conway	2007	65
12	Reinfection with hepatitis C virus following sustained virological response in injection drug users Journal of Gastroenterology and Hepatology ·Jason Grebely, Elizabeth Knight, Tyler Ngai, Krista Genoway, Jesse D. Raffa, Michelle Storms, Lesley Gallagher, Mel Krajden, Gregory J. Dore, Fiona Duncan, Brian Conway	2010	59
13	Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine AIDS ·Brian Conway, Mark A. Wainberg, David B. Hall, Marianne Harris, Peter Reiss, David A. Cooper, Stefano Vella, R. L. Curry, Patrick Robinson, Joep M. A. Lange, Julio Montaner	2001	52
14	Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada Journal of the International AIDS Society ·Sahar Saeed, Erin Strumpf, Erica E. M. Moodie, Jim Young, Roy Nitulescu, Joseph Cox, Alexander Wong, Sharon Walmsely, Curtis Cooper, Marie‐Lousie Vachon, Valérie Martel‐Laferrière, Mark Hull, Brian Conway, Marina B. Klein, (unknown)	2017	49
15	Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV Clinical Infectious Diseases ·Jim Young, Carmine Rossi, M. John Gill, Sharon Walmsley, Curtis Cooper, Joseph Cox, Valérie Martel‐Laferrière, Brian Conway, Neora Pick, Marie-Louise Vachon, Marina B. Klein, (unknown)	2017	41
16	Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting Open Forum Infectious Diseases ·Arshia Alimohammadi, Julie Holeksa, Astou Thiam, David Truong, Brian Conway	2018	35
17	Immunogenicity Is Not Improved by Increased Antigen Dose or Booster Dosing of Seasonal Influenza Vaccine in a Randomized Trial of HIV Infected Adults PLoS ONE ·Curtis Cooper, Anona Thorne, Marina B. Klein, Brian Conway, Guy Boivin, David Haase, Stephen D. Shafran, Wendy Zubyk, Joel Singer, Scott A. Halperin, Sharon Walmsley	2011	34
18	Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad^®Efficacy and Safety (SMiLES) HIV Clinical Trials ·José Antonio Vázquez, Lauren L. Patton, Joel B. Epstein, Padaruth Ramlachan, Ismail Mitha, Zoja Noveljic, Jan Fourie, Brian Conway, Rajesh V. Lalla, Andrei Barasch, P Attali	2010	34
19	A Randomized Phase 3 Study Comparing Once-Daily Elvitegravir With Twice-Daily Raltegravir in Treatment-Experienced Subjects With HIV-1 infection JAIDS Journal of Acquired Immune Deficiency Syndromes ·Richard Elion, Jean‐Michel Molina, José Ramón Arribas, David A. Cooper, Franco Maggiolo, Edmund Wilkins, Brian Conway, Ya-Pei Liu, Nicolas Margot, Martin S. Rhee, Steven L. Chuck, Javier Szwarcberg	2013	33
20	Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies Drug and Alcohol Dependence ·Graham R. Foster, Gregory J. Dore, Stanley Wang, Jason Grebely, Kenneth E. Sherman, Axel Baumgarten, Brian Conway, Daniel Jackson, Tarik Asselah, Michael Gschwantler, Krzysztof Tomasiewicz, Humberto Aguilar, Armen Asatryan, Yiran Hu, Federico Mensa	2018	29

About Brian Conway

Brian Conway is a scholar working on Hepatology, Virology, Infectious Diseases, Epidemiology and Emergency Medicine, having authored 86 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (55 papers), HIV/AIDS drug development and treatment (38 papers), Hepatitis B Virus Studies (31 papers), Liver Disease Diagnosis and Treatment (27 papers), HIV Research and Treatment (26 papers), HIV/AIDS Research and Interventions (24 papers), HIV, Drug Use, Sexual Risk (11 papers) and HIV-related health complications and treatments (5 papers). The work is most often cited by research in Hepatology (1.3k citations), Virology (458 citations), Infectious Diseases (889 citations), Epidemiology (1.5k citations) and Emergency Medicine (124 citations). Brian Conway has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Jason Grebely, Jesse D. Raffa, Mark Tyndall, Fiona Duncan, Krista Genoway, Mel Krajden, Stanley DeVlaming, Calvin Lai, Mark Viljoen and Milan Khara. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Hepatology, Clinical Infectious Diseases, HIV Clinical Trials and International Journal of Drug Policy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact